JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 3.28%72.45B | 3.84%48.25B | 3.34%23.97B | 2.00%94.01B | 2.14%70.15B | 2.16%46.46B | 2.50%23.2B | 6.45%92.17B | 6.34%68.68B | 6.58%45.48B |
Operating income | 3.84%48.25B | 2.00%94.01B | 2.16%46.46B | 6.45%92.17B | 6.58%45.48B | |||||
Operating expenses | ||||||||||
Gross profit | ||||||||||
Employee expense | ---- | -9.35%-4.38B | ---- | -11.39%-8.84B | ---- | -5.90%-4B | ---- | -15.49%-7.94B | ---- | -5.71%-3.78B |
Depreciation and amortization | ---- | -1.19%-24.9B | ---- | 0.98%-49.05B | ---- | 1.05%-24.61B | ---- | 0.90%-49.53B | ---- | -0.16%-24.87B |
Special items of operating profit | ---- | -3.72%-10.83B | ---- | -1.07%-21.61B | ---- | -7.14%-10.44B | ---- | -28.11%-21.39B | ---- | -23.10%-9.74B |
Operating profit | 9.87%8.15B | 8.94%14.5B | 4.58%7.41B | 2.13%13.31B | 11.57%7.09B | |||||
Financing income | ---- | 131.58%44M | ---- | -65.32%43M | ---- | 280.00%19M | ---- | 463.64%124M | ---- | -50.00%5M |
Financing cost | ---- | 5.95%-1.28B | ---- | 5.86%-2.83B | ---- | 15.36%-1.36B | ---- | 19.81%-3B | ---- | 14.24%-1.61B |
Special items of earning before tax | ---- | -55.12%127M | ---- | 1.74%1.11B | ---- | 272.37%283M | ---- | 261.39%1.1B | ---- | 10.14%76M |
Earning before tax | 11.29%10.76B | 10.73%7.04B | 12.13%3.69B | 11.31%12.83B | 14.51%9.67B | 14.26%6.36B | 15.61%3.29B | 19.90%11.53B | 21.75%8.44B | 22.03%5.56B |
Tax | ---- | -12.75%-1.71B | ---- | -12.44%-3.08B | ---- | -13.15%-1.51B | ---- | -19.85%-2.74B | ---- | -21.53%-1.34B |
After-tax profit from continuing operations | 10.10%5.33B | 10.96%9.75B | 14.61%4.84B | 19.91%8.79B | 22.19%4.22B | |||||
Earning after tax | 10.10%5.33B | 10.96%9.75B | 14.61%4.84B | 19.91%8.79B | 22.19%4.22B | |||||
Profit attributable to shareholders | 10.97%8.15B | 10.10%5.33B | 11.09%2.78B | 10.96%9.75B | 14.81%7.35B | 14.61%4.84B | 14.95%2.51B | 19.89%8.79B | 21.75%6.4B | 22.19%4.22B |
Basic earnings per share | 10.11%0.0305 | 10.93%0.0558 | 14.46%0.0277 | 20.05%0.0503 | 22.22%0.0242 | |||||
Diluted earnings per share | 10.11%0.0305 | 10.93%0.0558 | 14.46%0.0277 | 20.05%0.0503 | 22.22%0.0242 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.